Oppenheimer Asset Management Inc. Sells 3,016 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Oppenheimer Asset Management Inc. lessened its position in U.S. Physical Therapy, Inc. (NYSE:USPH) by 12.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 22,124 shares of the company’s stock after selling 3,016 shares during the quarter. Oppenheimer Asset Management Inc. owned about 0.15% of U.S. Physical Therapy worth $1,963,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of USPH. Venturi Wealth Management LLC increased its holdings in shares of U.S. Physical Therapy by 3,200.0% during the 4th quarter. Venturi Wealth Management LLC now owns 726 shares of the company’s stock worth $64,000 after purchasing an additional 704 shares during the period. KBC Group NV increased its holdings in shares of U.S. Physical Therapy by 68.6% during the 3rd quarter. KBC Group NV now owns 774 shares of the company’s stock worth $66,000 after purchasing an additional 315 shares during the period. Pacer Advisors Inc. bought a new position in shares of U.S. Physical Therapy during the 4th quarter worth about $113,000. First Horizon Advisors Inc. increased its holdings in shares of U.S. Physical Therapy by 25.1% during the 3rd quarter. First Horizon Advisors Inc. now owns 1,486 shares of the company’s stock worth $126,000 after purchasing an additional 298 shares during the period. Finally, International Assets Investment Management LLC increased its holdings in shares of U.S. Physical Therapy by 8,414.8% during the 3rd quarter. International Assets Investment Management LLC now owns 2,299 shares of the company’s stock worth $195,000 after purchasing an additional 2,272 shares during the period.

Insider Buying and Selling at U.S. Physical Therapy

In other news, CFO Carey P. Hendrickson sold 516 shares of the company’s stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $96.25, for a total transaction of $49,665.00. Following the transaction, the chief financial officer now directly owns 20,469 shares in the company, valued at approximately $1,970,141.25. This represents a 2.46 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.70% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently issued reports on USPH shares. Barrington Research dropped their price objective on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating on the stock in a report on Friday. JMP Securities started coverage on shares of U.S. Physical Therapy in a research report on Monday, December 16th. They set an “outperform” rating and a $113.00 target price on the stock. JPMorgan Chase & Co. lifted their target price on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the company an “overweight” rating in a research report on Tuesday, December 3rd. Citizens Jmp upgraded shares of U.S. Physical Therapy to a “strong-buy” rating in a research report on Monday, December 16th. Finally, William Blair reiterated a “market perform” rating on shares of U.S. Physical Therapy in a research report on Thursday. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, four have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $111.50.

U.S. Physical Therapy Price Performance

NYSE:USPH opened at $81.08 on Monday. The firm has a market cap of $1.22 billion, a PE ratio of 86.26, a price-to-earnings-growth ratio of 3.54 and a beta of 1.48. U.S. Physical Therapy, Inc. has a 12 month low of $76.18 and a 12 month high of $113.63. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. The company’s 50-day moving average price is $88.20 and its two-hundred day moving average price is $87.65.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing analysts’ consensus estimates of $0.69 by ($0.04). The firm had revenue of $180.45 million during the quarter, compared to analyst estimates of $173.10 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. On average, equities analysts anticipate that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 14th will be given a $0.45 dividend. The ex-dividend date of this dividend is Friday, March 14th. This represents a $1.80 dividend on an annualized basis and a yield of 2.22%. U.S. Physical Therapy’s dividend payout ratio (DPR) is presently 95.65%.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.